News & Articles

Discover how collaborative research between big pharma and academia is using the latest proteomics platforms to revolutionize drug discovery

Dr. David Andrews, AstraZeneca, discusses the future of small-molecule drug discovery for PPIs

Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more

Virender Singh shares his work, his average day, and favorite piece of laboratory equipment

In a ten-year project, a team from the Karl Landsteiner University of Health Sciences has identified a previously unknown role of calcium channels in the formation of synaptic connections

This week’s Reviewer in the Spotlight, Dr. Ritesh Bhole, discusses communication in science and the value of genuine product reviews, both positive and negative

Guest editor Dr. Klaus Lindpaintner discusses how innovations in glycoprotein characterization are advancing protein biology and medicine

The findings come from the largest study to date to look at inflammatory markers in COVID-19

Flow Eighteen38 will provide purified proteins and data to accelerate the success of antibody projects

The exploratory research project aims to develop novel protein expression systems via cell reprogramming

The acquisition will offer greater flow cytometry and imaging multiplexing capabilities to meet needs in protein and cell analysis research

Learn how the latest proteomics technology is driving large-scale, high-throughput studies in disease biology

From sample prep to downstream analysis, discover the products making a difference for other scientists in your field

From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18

From ultrafiltration and extraction to glycosylation and imaging, discover the latest technologies, top tips, and best practices for protein biology research

Watch world-renowned experts and connect with leading innovators on the hottest topics, new developments and latest technologies in neuroscience

Summa Equity Fund II acquires a majority stake in Sengenics, a functional proteomics company with a unique technology for production of full-length, correctly folded and functional proteins

Virus-fighting viperins, part of the human immune system, turn out to have bacterial counterparts that might boost the fight against human disease